SCHEMBL22591182

SCHEMBL22591182

CC(C)CC(Cl)c1ccc(CNC(=O)C(F)(F)F)cc1

nearest known ligand 0.45

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ HPGD P15428 1/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ LMNA P02545 1/20 0.41
▸ ANPEP P15144 2/20 0.40
▸ EPHX2 P34913 1/20 0.40
▸ NR1H4 Q96RI1 1/20 0.40
▸ HDAC6 Q9UBN7 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22591172 0.86 EPHX2 (0.41) SMN1; SMN2MEN1RAB9AKMT2AHPGD
SCHEMBL20289367 0.84 HPGD (0.42) SMN1; SMN2MEN1RAB9AKMT2AHPGD
SCHEMBL22572280 0.80 CNR1 (0.44) MEN1KMT2AALDH1A1HDAC6
SCHEMBL20289736 0.80 CNR1 (0.44) MEN1KMT2AALDH1A1HDAC6
SCHEMBL20289694 0.78 JAK1 (0.39) SMN1; SMN2MEN1RAB9AKMT2AEPHX2
Hydrochloric Acid SCHEMBL23235884 0.78 CA1 (0.42) SMN1; SMN2MEN1RAB9AKMT2AHPGD
SCHEMBL22591171 0.75 EPHX2 (0.42) SMN1; SMN2MEN1RAB9AKMT2AHPGD
SCHEMBL15013037 0.74 SMN1; SMN2 (0.56) SMN1; SMN2MEN1RAB9AKMT2AHPGD
SCHEMBL7767276 0.74 MEN1 (0.63) SMN1; SMN2MEN1RAB9AKMT2AHPGD
SCHEMBL7850276 0.74 RIPK1 (0.49) SMN1; SMN2RAB9AHPGDALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3763717-B1 PYRIDO[4,3-D][1,3]OXAZIN-2-ONE COMPOUNDS AS MUTANT IDH1 AND IDH2 INHIBITORS LILLY CO ELI (US) 2023-03-08 — — EP disclosed
EP-3763717-A1 PYRIDO[4,3-D][1,3]OXAZIN-2-ONE AND PYRIMIDO[4,5-D][1,3]OXAZIN-2-ONE COMPOUNDS AS MUTANT IDH1 AND IDH2 INHIBITORS ELI LILLY AND CO. (US) 2021-01-13 — — EP disclosed
EP-3555105-B1 7-PHENYLETHYLAMINO-4H-PYRIMIDO[4,5-D][1,3]OXAZIN-2-ONE COMPOUNDS AS MUTANT IDH1 AND IDH2 INHIBITORS LILLY CO ELI (US) 2020-10-28 — — EP disclosed
Send feedback